Transient reprogramming aims to shift aged cells towards a younger state without erasing cell identity.
It appears to target ageing itself rather than one disease and has produced striking cellular and animal findings.
Promising preclinical research; tissue response, durable benefit, delivery, dedifferentiation and tumour risk remain unresolved.
Frontier science, not an available longevity therapy.